Filling the need for trusted information on national health issues…

Trending on kff Open Enrollment Medicare Part D Medicaid Expansion

Kaiser Daily Global Health Policy ReportHIV/AIDS Search Results « » The Henry J. Kaiser Family Foundation


  • your selections
Clear Search

Filter Results



  • results
AIDS Mortality In China Drops By Nearly Two Thirds Since 2002 When Country Began Free Treatment Program

China’s HIV/AIDS-related mortality has dropped from 39.3 per 100 person-years in 2002 to 14.2 in 2009, or 64 percent, since the nation began providing free antiretroviral therapy (ART) in 2002, according to a study conducted by researchers from the Chinese Center for Disease Control and Prevention and published online Wednesday in Lancet Infectious Diseases, the New York Times reports (McNeil, 5/18).

People Living With HIV/AIDS In China Face Discrimination When Accessing Health Care, Report Says

HIV-positive people living in China “are routinely being denied medical treatment in mainstream hospitals due to fear and ignorance about the disease,” according to a study based on interviews with 103 people living with HIV/AIDS and 23 health care workers that was conducted by the International Labor Organization and China’s National Center for STD and AIDS Prevention and Control, Reuters reports (Wee, 5/17).

Recent Releases In Global Health

New U.N. Website: The new site focuses on the upcoming High Level Meeting on AIDS in New York, June 8-10, according to an update on the UNAIDS Facebook page. It includes program information, background materials and other details relevant to the meeting (5/18). Cultivating The WHO’s Strengths: This CSIS Global Health Policy Center…

OPINION: New HIV Infections More Expensive Than Providing Antiretroviral Drugs To Existing Patients

In light of study findings released last week showing the risk of HIV transmission can be reduced by 96 percent if HIV-positive patients begin combination antiretroviral therapy as soon as possible, a San Francisco Chronicle editorial asks, “The evidence is clearly starting to show that it’s much better to treat patients earlier, but from where will the money come?”